OR4N5: A Potential Drug Target and Biomarker (G390437)

OR4N5: A Potential Drug Target and Biomarker

OR4N5 (OR4N5_HUMAN), a protein that is expressed in human tissues, has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and subcellular localization make it an attractive target for small molecules, antibodies, or other therapeutic agents.

OR4N5 is a 21-kDa protein that is expressed in various tissues of the human body, including the brain, heart, lungs, kidneys, liver, and pancreas. It is primarily localized to the endoplasmic reticulum (ER), a protein-rich organ that plays a crucial role in the retrieval and processing of proteins from the cytoplasm. OR4N5 is a transmembrane protein, which means that it spans the cell membrane and is involved in various cellular processes, including signal transduction, protein-protein interactions, and intracellular signaling.

OR4N5 functions as a negative regulator of the microtubule dynamics in eukaryotic cells. It plays a critical role in the regulation of mitochondrial fusion and separation, which are essential for the proper functioning of cells. OR4N5 is also involved in the regulation of the cytoskeleton organization and stability, as well as in the control of cell division and apoptosis.

OR4N5 has been implicated in several diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. Its potential as a drug target and biomarker has been attributed to its unique structure and subcellular localization, as well as its involvement in various cellular processes that are crucial for human health and disease.

OR4N5 has been shown to be involved in the regulation of several cellular processes that are crucial for human health and disease. For example, studies have shown that OR4N5 is involved in the regulation of mitochondrial fusion and separation, which are essential for the proper functioning of cells. OR4N5 has also been shown to play a critical role in the regulation of the cytoskeleton organization and stability, as well as in the control of cell division and apoptosis.

In addition to its involvement in cellular processes, OR4N5 has also been shown to be involved in the regulation of several signaling pathways that are involved in cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that OR4N5 is involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of cell survival and proliferation. OR4N5 has also been shown to be involved in the regulation of the TGF-β signaling pathway, which is involved in the regulation of cell growth, differentiation, and survival.

Given its unique structure and subcellular localization, OR4N5 makes it an attractive target for small molecules, antibodies, or other therapeutic agents. Its involvement in various cellular processes and its involvement in several diseases and conditions make it a promising drug target and biomarker for the development of new therapeutic agents. Further research is needed to fully understand the role of OR4N5 in human health and disease, as well as to develop new therapeutic approaches for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders.

Protein Name: Olfactory Receptor Family 4 Subfamily N Member 5

Functions: Odorant receptor

The "OR4N5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR4N5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1 | OR52E2 | OR52E4 | OR52E5 | OR52E6 | OR52E8 | OR52H1 | OR52I1 | OR52I2 | OR52J3 | OR52K1 | OR52K2 | OR52K3P | OR52L1 | OR52M1 | OR52N1 | OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2 | OR5AK2 | OR5AK4P | OR5AN1 | OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P